Q2 FY2026 · ended Jun 30, 2026 · Revenue $4.02M, +309.1% YoY · Filed Aug 19, 2026
Regenerative Medical Technology Group Inc. (RMTG) files with the SEC under industry code 5990, Retail-Retail Stores, NEC. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $4.0 million and a net loss of $2.9 million. Free cash flow was $288,475. As of Jun 30, 2026 it held $1.3 million in cash and investments and $650,106 in total debt.
Revenue
$4.02M
+309.1% vs year-ago quarter
Net income
$-2.91M
-101.3% vs year-ago quarter
Operating cash flow
$331,974
+155.5% vs year-ago quarter
Free cash flow
$288,475
+144.4% vs year-ago quarter
EPS
$-0.22
-83.3% vs year-ago quarter
Dividend per share
None
Shares outstanding
13.74M
+9.6% vs year-ago quarter
Net cash
$673,198
Q2 FY2026
Operating margin
0.5%
TTM
Company profile
- Industry
- Retail-Retail Stores, NEC (SIC 5990)
- Listed as
- RMTG (OTC)
- Fiscal year ends
- December 31
- Headquarters
- Boca Raton, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1760026
- Former names
- MESO NUMISMATICS, INC. (until Oct 24, 2024)
Other Retail-Retail Stores, NEC companies
- JD.com, Inc. JD
- Ulta Beauty, Inc. ULTA
- Bath & Body Works, Inc. BBWI
- Sally Beauty Holdings, Inc. SBH
- ATRenew Inc. RERE
- Petco Health & Wellness Company, Inc. WOOF
- Titan Machinery Inc. TITN
- Star Group, L.P. SGU
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $4.0M | $2.6M | $1.6M | $1.2M | $983,318 |
| Operating income | $565,977 | $229,783 | -$306,274 | -$445,761 | -$250,087 |
| Net income | -$2.9M | -$876,274 | -$1.4M | -$4.4M | -$1.4M |
| Diluted EPS | -$0.22 | -$0.07 | -$0.11 | -$0.35 | -$0.12 |
| Operating cash flow | $331,974 | $102,124 | $38,196 | -$203,731 | -$598,093 |
| Free cash flow | $288,475 | -$213,270 | -$228,976 | -$428,560 | -$649,521 |
| Total assets | $5.9M | $5.0M | $4.5M | $4.5M | $4.5M |
| Total liabilities | $45.1M | $40.6M | $40.5M | $34.6M | $33.5M |
| Stockholders' equity | -$39.3M | -$36.4M | -$36.0M | -$30.1M | -$29.0M |
| Cash and investments | $1.3M | $1.1M | $956,718 | $1.2M | $1.6M |
| Total debt | $650,106 | $591,731 | $629,083 | $543,788 | $273,461 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Aug 25, 2026 | Aug 20, 2026 |
| 10-Q | Quarterly report | Aug 19, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | Jun 9, 2026 | Mar 31, 2026 |
| 10-K | Annual report | May 14, 2026 | Dec 31, 2025 |
| 10-Q | Quarterly report | Nov 19, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 19, 2025 | Jun 30, 2025 |
All 101 Regenerative Medical Technology Group Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.